IL1B and Alzheimer disease: In addition, IL-1β, which increases in the brain as inflammation progresses, was found in the hippocampus at significantly lower levels in anserine-treated than in untreated AD mice (p = 0.02, Student’s t-test) (Fig. 7), indicating that anserine suppressed glial neuroinflammatory reactions in the AD brain.